{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:58:52Z","timestamp":1792083532111,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cca.2026.121300","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:08:42Z","timestamp":1788044922000},"page":"121300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analytical validation and clinical performance of a chemiluminescence immunoassay panel for plasma biomarkers in Alzheimer\u2019s disease: a preliminary study"],"prefix":"10.1016","volume":"593","author":[{"given":"Ximeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121300_bb0005","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327\u2013406. Doi:https:\/\/doi.org\/10.1002\/alz.12328.","DOI":"10.1002\/alz.12328"},{"issue":"10284","key":"10.1016\/j.cca.2026.121300_bb0010","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"5580","key":"10.1016\/j.cca.2026.121300_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cca.2026.121300_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.cca.2026.121300_bb0025","article-title":"Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer\u2019s disease","volume":"15","author":"Giangrande","year":"2023","journal-title":"Alzheimers Dement (Amst)."},{"issue":"8","key":"10.1016\/j.cca.2026.121300_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70472","article-title":"Integrating neuroinflammation biomarkers into the ATN(X) framework: advances in Alzheimer\u2019s pathogenesis, diagnosis, and insights from non-human primate models","volume":"21","author":"Jin","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.cca.2026.121300_bb0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S104161022100274X","article-title":"Postoperative delirium and its relationship with biomarkers for dementia: a meta-analysis","volume":"34","author":"Wang","year":"2022","journal-title":"Int. Psychogeriatr."},{"issue":"4","key":"10.1016\/j.cca.2026.121300_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3988\/jcn.2022.18.4.401","article-title":"Promising blood biomarkers for clinical use in Alzheimer\u2019s disease: a focused update","volume":"18","author":"Park","year":"2022","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13041-019-0448-1","article-title":"Blood-based molecular biomarkers for Alzheimer\u2019s disease","volume":"12","author":"Zetterberg","year":"2019","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40035-023-00365-x","article-title":"Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints","volume":"12","author":"Lu","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13195-025-01803-w","article-title":"Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort","volume":"17","author":"Dresse","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"8","key":"10.1016\/j.cca.2026.121300_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47080580","article-title":"From amyloid to synaptic dysfunction: biomarker-driven insights into Alzheimer\u2019s disease","volume":"47","author":"Agnello","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"4","key":"10.1016\/j.cca.2026.121300_bb0065","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-026-08931-7","volume":"47","author":"Gaetani","year":"2026","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.121300_bb0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.cca.2026.121300_bb0075","doi-asserted-by":"crossref","first-page":"499r","DOI":"10.1021\/ac00108a035","article-title":"Chemiluminescence and bioluminescence","volume":"67","author":"Kricka","year":"1995","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.cca.2026.121300_bb0080","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/alz.13687","article-title":"Fully automated measurement of plasma A\u03b242\/40 and p-tau181: analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer\u2019s disease continuum in two independent cohorts","volume":"20","author":"Bellomo","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"17","key":"10.1016\/j.cca.2026.121300_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179561","article-title":"Validation study of a new random-access Chemiluminescence immunoassay analyzer i-TRACK10(\u00ae) to monitor infliximab and adalimumab serum trough levels and anti-drug antibodies","volume":"23","author":"Berger","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cca.2026.121300_bb0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.cca.2026.121300_bb0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma biomarkers of Alzheimer\u2019s disease: a review of available assays, recent developments, and implications for clinical practice","volume":"7","author":"Pais","year":"2023","journal-title":"J Alzheimers Dis Rep."},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0110","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/s41598-024-66923-z","article-title":"Evaluation of core biomarkers of Alzheimer\u2019s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform","volume":"14","author":"Agnello","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.121300_bb0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tibtech.2004.03.011","article-title":"Biotechnological applications of bioluminescence and chemiluminescence","volume":"22","author":"Roda","year":"2004","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.cca.2026.121300_bb0120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of Cerebrospinal Fluid Neurofilament Light Protein Levels with Cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.cca.2026.121300_bb0125","first-page":"453","article-title":"Nucleic acid detection technologies -- labels, strategies, and formats","volume":"45","author":"Kricka","year":"1999","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2026.121300_bb0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.cca.2026.121300_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70038","article-title":"Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cca.2026.121300_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3343\/alm.2018.38.2.85","article-title":"Multi-center performance evaluations of tacrolimus and cyclosporine electrochemiluminescence immunoassays in the Asia-Pacific region","volume":"38","author":"Qin","year":"2018","journal-title":"Ann. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00415-025-13556-5","article-title":"Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer\u2019s disease","volume":"273","author":"Guill\u00e9n","year":"2025","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2026.121300_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-025-01932-2","article-title":"Recent molecular insights and biosensor-based diagnostic technologies for hyperphosphorylated tau in Alzheimer\u2019s disease","volume":"18","author":"Shabana","year":"2025","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.cca.2026.121300_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27104518","article-title":"Analytical methods for fluid biomarkers in Alzheimer\u2019s disease from discovery to clinical implementation","volume":"27","author":"Agnello","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121300_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jalz.2012.11.003","article-title":"Global standardization measurement of cerebral spinal fluid for Alzheimer\u2019s disease: an update from the Alzheimer\u2019s Association global biomarkers consortium","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.cca.2026.121300_bb0165","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.cca.2026.121300_bb0170","doi-asserted-by":"crossref","unstructured":"Bu XL, Liu ZT, Xin JY, Huang M, Bai YD, Zhou J, et al. Associations of plasma and CSF osteocalcin levels with CSF ATN biomarkers and cognitive functions in Alzheimer's disease. MedComm 2025;6(7):e70255. Doi:https:\/\/doi.org\/10.1002\/mco2.70255.","DOI":"10.1002\/mco2.70255"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:59Z","timestamp":1792081559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":34,"alternative-id":["S0009898126004821"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121300","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical validation and clinical performance of a chemiluminescence immunoassay panel for plasma biomarkers in Alzheimer\u2019s disease: a preliminary study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121300"}}